Integrative bioinformatics analysis to screen key genes and signalling pathways related to ferroptosis in obesity

References

• Wharton S, Lau DCW, Vallis M, et al. Obesity in adults: a clinical practice guideline. Can Med Assoc J. 2020;192(31):E875–E91. doi: 10.1503/cmaj.191707
   PubMed Web of Science ®Google Scholar
• Qasim A, Turcotte M, de Souza RJ, et al. On the origin of obesity: identifying the biological, environmental and cultural drivers of genetic risk among human populations. Obes Rev. 2018;19(2):121–16. doi: 10.1111/obr.12625
   PubMed Web of Science ®Google Scholar
• Hill JJ. Obesity: an emerging threat. J Natl Black Nurses Assoc. 2018;29:36–39.
   PubMedGoogle Scholar
• Danaei G, Finucane MM, Lu Y, et al. National, regional, and global trends in fasting plasma glucose and diabetes prevalence since 1980: systematic analysis of health examination surveys and epidemiological studies with 370 country-years and 2·7 million participants. Lancet. 2011;378(9785):31–40. doi: 10.1016/S0140-6736(11)60679-X
   PubMed Web of Science ®Google Scholar
• Kivimaki M, Kuosma E, Ferrie JE, et al. Overweight, obesity, and risk of cardiometabolic multimorbidity: pooled analysis of individual-level data for 120 813 adults from 16 cohort studies from the USA and Europe. Lancet Public Health. 2017;2(6):e277–e85. doi: 10.1016/S2468-2667(17)30074-9
   PubMed Web of Science ®Google Scholar
• Fang Z, Giovannucci EL. The timing of adiposity and changes in the life course on the risk of cancer. Cancer Metastasis Rev. 2022;41(3):471–489. doi: 10.1007/s10555-022-10054-2
   PubMed Web of Science ®Google Scholar
• Klein R. Hyperglycemia and microvascular and macrovascular disease in diabetes. Diabetes Care. 1995;18(2):258–268. doi: 10.2337/diacare.18.2.258
   PubMed Web of Science ®Google Scholar
• Bommer C, Sagalova V, Heesemann E, et al. Global economic burden of diabetes in adults: projections from 2015 to 2030. Diabetes Care. 2018;41(5):963–970. doi: 10.2337/dc17-1962
   PubMed Web of Science ®Google Scholar
• Nguyen T, Lau DC. The obesity epidemic and its impact on hypertension. Can J Cardiol. 2012;28(3):326–333. doi: 10.1016/j.cjca.2012.01.001
   PubMed Web of Science ®Google Scholar
• Zhang T, Zhang H, Li S, et al. Impact of adiposity on incident hypertension is modified by insulin resistance in adults: longitudinal observation from the Bogalusa heart study. Hypertension. 2016;67(1):56–62. doi: 10.1161/HYPERTENSIONAHA.115.06509
   PubMed Web of Science ®Google Scholar
• Dixon SJ, Lemberg KM, Lamprecht MR, et al. Ferroptosis: an iron-dependent form of nonapoptotic cell death. Cell. 2012;149(5):1060–1072. doi: 10.1016/j.cell.2012.03.042
   PubMed Web of Science ®Google Scholar
• Zhang JJ, Du J, Kong N, et al. Mechanisms and pharmacological applications of ferroptosis: a narrative review. Ann Transl Med. 2021;9(19):1503. doi: 10.21037/atm-21-1595
   PubMed Web of Science ®Google Scholar
• Du H, Ren X, Bai J, et al. Research Progress of ferroptosis in adiposity-Based chronic disease (ABCD). Oxid Med Cell Longev. 2022;2022:1052699. doi: 10.1155/2022/1052699
   PubMed Web of Science ®Google Scholar
• Stockwell BR, Friedmann Angeli JP, Bayir H, et al. Ferroptosis: a regulated cell death nexus linking metabolism, redox Biology, and disease. Cell. 2017;171(2):273–285. doi: 10.1016/j.cell.2017.09.021
   PubMed Web of Science ®Google Scholar
• Hu W, Liang K, Zhu H, et al. Ferroptosis and its role in chronic diseases. Cells. 2022;11(13):2040. doi: 10.3390/cells11132040
   PubMed Web of Science ®Google Scholar
• Yan HF, Zou T, Tuo QZ, et al. Ferroptosis: mechanisms and links with diseases. Signal Transduct Target Ther. 2021;6(1):49. doi: 10.1038/s41392-020-00428-9
   PubMed Web of Science ®Google Scholar
• Oshaug A, Bugge KH, Bjonnes CH, et al. Associations between serum ferritin and cardiovascular risk factors in healthy young men. A cross sectional study. Eur J Clin Nutr. 1995;49:430–438.
   PubMed Web of Science ®Google Scholar
• Zhang Z, Funcke JB, Zi Z, et al. Adipocyte iron levels impinge on a fat-gut crosstalk to regulate intestinal lipid absorption and mediate protection from obesity. Cell Metab. 2021;33(8):1624–39 e9. doi: 10.1016/j.cmet.2021.06.001
   PubMed Web of Science ®Google Scholar
• Ikeda Y, Funamoto M, Tsuchiya K. The role of iron in obesity and diabetes. J Med Invest. 2022;69(1.2):1–7. doi: 10.2152/jmi.69.1
   PubMed Web of Science ®Google Scholar
• Furukawa S, Fujita T, Shimabukuro M, et al. Increased oxidative stress in obesity and its impact on metabolic syndrome. J Clin Invest. 2004;114(12):1752–1761. doi: 10.1172/JCI21625
   PubMed Web of Science ®Google Scholar
• Luo Y, Chen H, Liu H, et al. Protective effects of ferroptosis inhibition on high fat diet-induced liver and renal injury in mice. Int J Clin Exp Pathol. 2020;13:2041–2049.
   PubMed Web of Science ®Google Scholar
• Ritchie ME, Phipson B, Wu D, et al. Limma powers differential expression analyses for RNA-sequencing and microarray studies. Nucleic Acids Res. 2015;43(7):e47. doi: 10.1093/nar/gkv007
   PubMed Web of Science ®Google Scholar
• Yu G, Wang LG, Han Y, et al. clusterProfiler: an R package for comparing biological themes among gene clusters. OMICS. 2012;16(5):284–287. doi: 10.1089/omi.2011.0118
   PubMed Web of Science ®Google Scholar
• Langfelder P, Horvath S. WGCNA: an R package for weighted correlation network analysis. BMC Bioinf. 2008;9(1):559. doi: 10.1186/1471-2105-9-559
   PubMed Web of Science ®Google Scholar
• Hubler MJ, Peterson KR, Hasty AH. Iron homeostasis: a new job for macrophages in adipose tissue? Trends Endocrinol Metab. 2015;26(2):101–109. doi: 10.1016/j.tem.2014.12.005
   PubMed Web of Science ®Google Scholar
• Ameka MK, Beavers WN, Shaver CM, et al. An iron refractory phenotype in obese adipose tissue macrophages leads to adipocyte iron overload. Int J Mol Sci. 2022;23(13):7417. doi: 10.3390/ijms23137417
   PubMed Web of Science ®Google Scholar
• Masarone M, Rosato V, Dallio M, et al. Role of oxidative stress in pathophysiology of nonalcoholic fatty liver disease. Oxid Med Cell Longev. 2018;2018:9547613. doi: 10.1155/2018/9547613
   PubMed Web of Science ®Google Scholar
• Rumberger JM, Peters T Jr., Burrington C, et al. Transferrin and iron contribute to the lipolytic effect of serum in isolated adipocytes. Diabetes. 2004;53(10):2535–2541. doi: 10.2337/diabetes.53.10.2535
   PubMed Web of Science ®Google Scholar
• Green A, Basile R, Rumberger JM. Transferrin and iron induce insulin resistance of glucose transport in adipocytes. Metabolism. 2006;55(8):1042–1045. doi: 10.1016/j.metabol.2006.03.015
   PubMed Web of Science ®Google Scholar
• Chen D, Fan Z, Rauh M, et al. ATF4 promotes angiogenesis and neuronal cell death and confers ferroptosis in a xCT-dependent manner. Oncogene. 2017;36(40):5593–5608. doi: 10.1038/onc.2017.146
   PubMed Web of Science ®Google Scholar
• Priceman SJ, Kujawski M, Shen S, et al. Regulation of adipose tissue T cell subsets by Stat3 is crucial for diet-induced obesity and insulin resistance. Proc Natl Acad Sci U S A. 2013;110(32):13079–13084. doi: 10.1073/pnas.1311557110
   PubMed Web of Science ®Google Scholar
• Shi M, Lin Z, Ye L, et al. Estrogen receptor-regulated SOCS3 modulation via JAK2/STAT3 pathway is involved in BPF-induced M1 polarization of macrophages. Toxicology. 2020;433-434:152404. doi: 10.1016/j.tox.2020.152404
   PubMed Web of Science ®Google Scholar
• Zhang C, Yue C, Herrmann A, et al. STAT3 activation-induced fatty acid oxidation in CD8(+) T effector cells is critical for obesity-promoted breast tumor growth. Cell Metab. 2020;31(1):148–61 e5. doi: 10.1016/j.cmet.2019.10.013
   PubMed Web of Science ®Google Scholar
• Ouyang S, Li H, Lou L, et al. Inhibition of STAT3-ferroptosis negative regulatory axis suppresses tumor growth and alleviates chemoresistance in gastric cancer. Redox Biol. 2022;52:102317. doi: 10.1016/j.redox.2022.102317
   PubMed Web of Science ®Google Scholar
• Liu R, Wang M, Li E, et al. Dysregulation of microRNA-125a contributes to obesity-associated insulin resistance and dysregulates lipid metabolism in mice. Biochim Biophys Acta, Mol Cell Biol Lipids. 2020;1865(5):158640. doi: 10.1016/j.bbalip.2020.158640
   PubMed Web of Science ®Google Scholar
• Xu L, Li Y, Yin L, et al. miR-125a-5p ameliorates hepatic glycolipid metabolism disorder in type 2 diabetes mellitus through targeting of STAT3. Theranostics. 2018;8(20):5593–5609. doi: 10.7150/thno.27425
   PubMed Web of Science ®Google Scholar
• Makar KW, Poole EM, Resler AJ, et al. COX-1 (PTGS1) and COX-2 (PTGS2) polymorphisms, NSAID interactions, and risk of colon and rectal cancers in two independent populations. Cancer Causes Control. 2013;24(12):2059–2075. doi: 10.1007/s10552-013-0282-1
   PubMed Web of Science ®Google Scholar
• Ma W, Jia L, Xiong Q, et al. Iron overload protects from obesity by Ferroptosis. Foods. 2021;10(8):1787. doi: 10.3390/foods10081787
   PubMed Web of Science ®Google Scholar
• Chan PC, Hsiao FC, Chang HM, et al. Importance of adipocyte cyclooxygenase-2 and prostaglandin E2-prostaglandin E receptor 3 signaling in the development of obesity-induced adipose tissue inflammation and insulin resistance. FASEB J. 2016;30(6):2282–2297. doi: 10.1096/fj.201500127
   PubMed Web of Science ®Google Scholar
• Chan PC, Wu TN, Chen YC, et al. Targetted inhibition of CD74 attenuates adipose COX-2-MIF-mediated M1 macrophage polarization and retards obesity-related adipose tissue inflammation and insulin resistance. Clin Sci (Lond). 2018;132(14):1581–1596. doi: 10.1042/CS20180041
   PubMed Web of Science ®Google Scholar
• Zhao X, Si L, Bian J, et al. Adipose tissue macrophage-derived exosomes induce ferroptosis via glutathione synthesis inhibition by targeting SLC7A11 in obesity-induced cardiac injury. Free Radic Biol Med. 2022;182:232–245. doi: 10.1016/j.freeradbiomed.2022.02.033
   PubMed Web of Science ®Google Scholar
• Apte RS, Chen DS, Ferrara N. VEGF in signaling and disease: beyond discovery and development. Cell. 2019;176(6):1248–1264. doi: 10.1016/j.cell.2019.01.021
   PubMed Web of Science ®Google Scholar
• Sun K, Wernstedt Asterholm I, Kusminski CM, et al. Dichotomous effects of VEGF-A on adipose tissue dysfunction. Proc Natl Acad Sci U S A. 2012;109(15):5874–5879. doi: 10.1073/pnas.1200447109
   PubMed Web of Science ®Google Scholar
• Shimizu I, Aprahamian T, Kikuchi R, et al. Vascular rarefaction mediates whitening of brown fat in obesity. J Clin Invest. 2014;124(5):2099–2112. doi: 10.1172/JCI71643
   PubMed Web of Science ®Google Scholar
• Jing X, Wu J, Dong C, et al. COVID-19 instigates adipose browning and atrophy through VEGF in small mammals. Nat Metab. 2022;4(12):1674–1683. doi: 10.1038/s42255-022-00697-4
   PubMedGoogle Scholar
• Ortega FJ, Mercader JM, Catalan V, et al. Targeting the circulating microRNA signature of obesity. Clin Chem. 2013;59(5):781–792. doi: 10.1373/clinchem.2012.195776
   PubMed Web of Science ®Google Scholar
• Zhu Z, Gan X, Yu H. NF-κB-miR15a-bFGF/VEGFA axis contributes to the impaired angiogenic capacity of BM-MSCs in high fat diet-fed mice. Mol Med Rep. 2017;16(5):7609–7616. doi: 10.3892/mmr.2017.7498
   PubMed Web of Science ®Google Scholar
• Zhan S, Wang C, Yin F. MicroRNA-29c inhibits proliferation and promotes apoptosis in non-small cell lung cancer cells by targeting VEGFA. Mol Med Rep. 2018;17:6705–6710. doi: 10.3892/mmr.2018.8678
   PubMed Web of Science ®Google Scholar
• Covarrubias AJ, Horng T. IL-6 strikes a balance in metabolic inflammation. Cell Metab. 2014;19(6):898–899. doi: 10.1016/j.cmet.2014.05.009
   PubMed Web of Science ®Google Scholar
• Wedell-Neergaard AS, Lang Lehrskov L, Christensen RH, et al. Exercise-induced changes in visceral adipose tissue mass are regulated by IL-6 signaling: a randomized controlled trial. Cell Metab. 2019;29(4):844–55 e3. doi: 10.1016/j.cmet.2018.12.007
   PubMed Web of Science ®Google Scholar
• Han MS, White A, Perry RJ, et al. Regulation of adipose tissue inflammation by interleukin 6. Proc Natl Acad Sci U S A. 2020;117(6):2751–2760. doi: 10.1073/pnas.1920004117
   PubMed Web of Science ®Google Scholar
• Bin S, Xin L, Lin Z, et al. Targeting miR-10a-5p/IL-6R axis for reducing IL-6-induced cartilage cell ferroptosis. Exp Mol Pathol. 2021;118:104570. doi: 10.1016/j.yexmp.2020.104570
   PubMed Web of Science ®Google Scholar
• Zheng S, Guo S, Sun G, et al. Gain of metabolic benefit with ablation of miR-149-3p from subcutaneous adipose tissue in diet-induced obese mice. Mol Ther Nucleic Acids. 2019;18:194–203. doi: 10.1016/j.omtn.2019.07.024
   PubMedGoogle Scholar
• Ahmadpour F, Nourbakhsh M, Razzaghy-Azar M, et al. The Association of plasma levels of miR-34a and miR-149 with obesity and insulin resistance in obese children and adolescents. Acta Endo (Buc). 2018;14(2):149–154. doi: 10.4183/aeb.2018.149
   PubMed Web of Science ®Google Scholar
• Maixner N, Pecht T, Haim Y, et al. A TRAIL-TL1A Paracrine network Involving adipocytes, macrophages, and lymphocytes induces adipose tissue dysfunction downstream of E2F1 in human obesity. Diabetes. 2020;69(11):2310–2323. doi: 10.2337/db19-1231
   PubMed Web of Science ®Google Scholar
• Costantino S, Akhmedov A, Melina G, et al. Obesity-induced activation of JunD promotes myocardial lipid accumulation and metabolic cardiomyopathy. Eur Heart J. 2019;40(12):997–1008. doi: 10.1093/eurheartj/ehy903
   PubMed Web of Science ®Google Scholar
• Nishimura Y, Sasagawa S, Ariyoshi M, et al. Systems pharmacology of adiposity reveals inhibition of EP300 as a common therapeutic mechanism of caloric restriction and resveratrol for obesity. Front Pharmacol. 2015;6:199. doi: 10.3389/fphar.2015.00199
   PubMed Web of Science ®Google Scholar
• Cox AR, Chernis N, Bader DA, et al. STAT1 dissociates adipose tissue inflammation from insulin sensitivity in obesity. Diabetes. 2020;69(12):2630–2641. doi: 10.2337/db20-0384
   PubMed Web of Science ®Google Scholar
• Esser N, Paquot N, Scheen AJ. Anti-inflammatory agents to treat or prevent type 2 diabetes, metabolic syndrome and cardiovascular disease. Expert Opin Investig Drugs. 2015;24(3):283–307. doi: 10.1517/13543784.2015.974804
   PubMed Web of Science ®Google Scholar
• Saraswathi V, Heineman R, Alnouti Y, et al. A combination of omega-3 PUFAs and COX inhibitors: a novel strategy to manage obesity-linked dyslipidemia and adipose tissue inflammation. J Diabetes Complications. 2020;34(2):107494. doi: 10.1016/j.jdiacomp.2019.107494
   PubMed Web of Science ®Google Scholar
• Dey A, Maric C, Kaesemeyer WH, et al. Rofecoxib decreases renal injury in obese Zucker rats. Clin Sci (Lond). 2004;107(6):561–570. doi: 10.1042/CS20040125
   PubMed Web of Science ®Google Scholar
• Kunnumakkara AB, Bordoloi D, Padmavathi G, et al. Curcumin, the golden nutraceutical: multitargeting for multiple chronic diseases. Br J Pharmacol. 2017;174(11):1325–1348. doi: 10.1111/bph.13621
   PubMed Web of Science ®Google Scholar
• Murtaza M, Khan G, Aftab MF, et al. Cucurbitacin E reduces obesity and related metabolic dysfunction in mice by targeting JAK-STAT5 signaling pathway. PLoS One. 2017;12(6):e0178910. doi: 10.1371/journal.pone.0178910
   PubMed Web of Science ®Google Scholar
• Camer D, Yu Y, Szabo A, et al. Bardoxolone methyl prevents insulin resistance and the development of hepatic steatosis in mice fed a high-fat diet. Mol Cell Endocrinol. 2015;412:36–43. doi: 10.1016/j.mce.2015.05.018
   PubMed Web of Science ®Google Scholar
• Kim ID, Cave JW, Cho S. Aflibercept, a VEGF (vascular endothelial growth factor)-trap, reduces vascular permeability and stroke-induced brain swelling in obese mice. Stroke. 2021;52(8):2637–2648. doi: 10.1161/STROKEAHA.121.034362
   PubMed Web of Science ®Google Scholar